Anterior cord syndrome

Background
  • Etiology
    • Direct anterior Cord Compression (e.g. disc protrusion, posterior abdominal aortic aneurysm, mass)
    • Hyperflexion injury of cervical spine
    • Thrombosis of anterior spinal artery
Spinal cord tracts

Clinical Features
  • Paraplegia below level of lesion (corticospinal)
  • Loss of pain/temperature (lateral spinothalamic)
  • Autonomic dysfunction, orthostasis
  • Bowel, bladder, sexual dysfunction
  • Preservation of modalities carried by dorsal columns i.e. vibration, proprioception, 2-point discrimination

Differential Diagnosis

Spinal Cord Syndromes

Evaluation

Management
  • Consider intubation injuries at C5 or above
  • Consider surgical intervention for:
  • Steroids are no longer recommended
    • Administration of methylprednisolone (MP) for the treatment of acute spinal cord injury (SCI) is not recommended. Clinicians considering MP therapy should bear in mind that the drug is not Food and Drug Administration (FDA) approved for this application. There is no Class I or Class II medical evidence supporting the clinical benefit of MP in the treatment of acute SCI. Scattered reports of Class III evidence claim inconsistent effects likely related to random chance or selection bias. However, Class I, II, and III evidence exists that high-dose steroids are associated with harmful side effects including death.[1]
    • See EBQ:High Dose Steroids in Cord Injury for further discussion
  • Neurogenic shock management

Prognosis
  • Poor

Disposition
  • Admit

See Also
  • Spinal cord syndromes

References
  1. Hurlbert RJ et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery. 2013 Mar;72 Suppl 2:93-105 http://www.ncbi.nlm.nih.gov/pubmed/23417182
This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.